Literature DB >> 20724549

Evidence against a protein in plasma that is a product of a factor XI mRNA splice variant missing exons 6 and 7.

David Gailani, Mao-Fu Sun, Qiufang Cheng, Anton Matafonov, Erik I Tucker, Andras Gruber, Jonas Emsley.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20724549      PMCID： PMC2938133          DOI： 10.1182/blood-2010-01-265702

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

1.  Identification of amino acids in the factor XI apple 3 domain required for activation of factor IX.

Authors:  M F Sun; M Zhao; D Gailani
Journal:  J Biol Chem       Date:  1999-12-17       Impact factor: 5.157

2.  Crystal structure of the factor XI zymogen reveals a pathway for transactivation.

Authors:  Evangelos Papagrigoriou; Paul A McEwan; Peter N Walsh; Jonas Emsley
Journal:  Nat Struct Mol Biol       Date:  2006-05-14       Impact factor: 15.369

3.  Molecular modeling of the prekallikrein structure provides insights into high-molecular-weight kininogen binding and zymogen activation.

Authors:  E Hooley; P A McEwan; J Emsley
Journal:  J Thromb Haemost       Date:  2007-10-08       Impact factor: 5.824

4.  Identification of a factor IX binding site on the third apple domain of activated factor XI.

Authors:  Y Sun; D Gailani
Journal:  J Biol Chem       Date:  1996-11-15       Impact factor: 5.157

5.  Human blood coagulation factor XI. Purification, properties, and mechanism of activation by activated factor XII.

Authors:  B N Bouma; J H Griffin
Journal:  J Biol Chem       Date:  1977-09-25       Impact factor: 5.157

6.  Organization of the gene for human factor XI.

Authors:  R Asakai; E W Davie; D W Chung
Journal:  Biochemistry       Date:  1987-11-17       Impact factor: 3.162

7.  Amino acid sequence of human factor XI, a blood coagulation factor with four tandem repeats that are highly homologous with plasma prekallikrein.

Authors:  K Fujikawa; D W Chung; L E Hendrickson; E W Davie
Journal:  Biochemistry       Date:  1986-05-06       Impact factor: 3.162

8.  Factor XI contributes to thrombin generation in the absence of factor XII.

Authors:  Dmitri V Kravtsov; Anton Matafonov; Erik I Tucker; Mao-Fu Sun; Peter N Walsh; Andras Gruber; David Gailani
Journal:  Blood       Date:  2009-04-07       Impact factor: 22.113

9.  Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI.

Authors:  Erik I Tucker; Ulla M Marzec; Tara C White; Sawan Hurst; Sandra Rugonyi; Owen J T McCarty; David Gailani; András Gruber; Stephen R Hanson
Journal:  Blood       Date:  2008-10-22       Impact factor: 22.113

10.  Molecular characterization of in-frame and out-of-frame alternative splicings in coagulation factor XI pre-mRNA.

Authors:  Rosanna Asselta; Valeria Rimoldi; Ilaria Guella; Giulia Soldà; Raimondo De Cristofaro; Flora Peyvandi; Stefano Duga
Journal:  Blood       Date:  2009-12-30       Impact factor: 22.113
  10 in total
  1 in total

Review 1.  Factor XI and XII as antithrombotic targets.

Authors:  Felicitas Müller; David Gailani; Thomas Renné
Journal:  Curr Opin Hematol       Date:  2011-09       Impact factor: 3.284
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.